Association of vitamin D levels with severity and outcome of COVID-19 infection among inward patients at a tertiary care unit in Sri Lanka
P Mayurathan, G R Francis, V R Francis, S I Majitha, R Sanjeev, S Vivekanandan, S Santharooban, W M U Nishantha, M M N Peries, A S M Safran, S Shiyananth
Asian Journal of Internal Medicine, doi:10.4038/ajim.v2i2.84
Introduction: A link between vitamin D and COVID-19 infection has been expressed by many experts. In this study, we aim to investigate the association of the prevalence of vitamin D deficiency with the severity and outcome of COVID-19 infection in patients who are admitted to Teaching Hospital Batticaloa, Sri Lanka. Methods: A retrospective cross-sectional study was conducted among COVID-19 patients over a period of one month in May 2021. All patients who tested positive for COVID-19 were included. Patients with chronic kidney disease, known vitamin D deficiency, and patients on vitamin D supplements were excluded from the study. The vitamin D deficiency was defined according to the Oxford Academic Endocrine Society guidelines. The severity of the COVID-19 was defined according to the Provisional Clinical Practice Guidelines on COVID-19 suspected and confirmed patients. Primary endpoints of this study were 'recovered from COVID-19' or 'death'. Data was analysed to report the proportion of patients with different vitamin D levels and disease severity. Chi-squared and Fisher's exact tests were used to analyse the results. A p-value of <0.05 was considered as statistically significant. Results: Out of 141, 58% were males. Mild, moderate, and severe COVID-19 were observed in 29.8%, 48.2%, and 22.0% of patients respectively. Only 30.5% of the population had normal vitamin D levels while the rest had some degree of vitamin D insufficiency. None of the patient population had severe vitamin D deficiency status. A 52.9% in the moderate category of COVID-19 severity had insufficient levels of vitamin D levels. Those that recovered from COVID-19 were 93.6%. No significant association was observed between the severity of COVID-19 and vitamin D deficiency (p=.1041). Interestingly hypoxia was significantly prevalent among those with normal vitamin D levels (p=.0005). vitamin D deficiency does not impact the mortality rate among COVID-19 patients (p=.6559). Conclusions: The association of vitamin D levels with COVID-19 severity and mortality was not statistically significant.
References
Borsche, Glauner, Mendel, COVID-19 Mortality Risk Correlates Inversely with vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis, Nutrients,
doi:10.3390/nu13103596Campi, Gennari, Merlotti, vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect Dis,
doi:10.1186/s12879-021-06281-7Chen, Mei, Xie, Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs,
doi:10.1038/s41598-022-21513-9Dissanayake, Silva, Sumanatilleke, Prognostic and Therapeutic Role of vitamin D in COVID-19: Systematic Review and Meta-analysis, J Clin Endocrinol Metab,
doi:10.1210/clinem/dgab892Ferrari, Locatelli, No significant association between vitamin D and COVID-19: A retrospective study from a northern Italian hospital, Int J Vitam Nutr Res,
doi:10.1024/0300-9831/a000687Francis, Sooriyaarachchi, Jayawardena, Usage of nutritional supplements to improve immunity during the COVID-19 pandemic: An online survey, Clin Nutr Open Sci
Gibson, Qin, Puah, COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS, Med. J. Aust
Holick, Binkley, Bischoff-Ferrari, Provisional Clinical Practice Guidelines on COVID-19 suspected and confirmed by Ministry of Heath, Sri Lanka in collaboration with Ceylon College of Physicians coordinated by epidemiology unit: 4th version,
doi:10.1210/jc.2011-0385Jayatissa, Lekamwasam, Ranbanda, vitamin D deficiency among children aged 10-18 years in Sri Lanka, Ceylon Medical Journal,
doi:10.4038/cmj.v64i4.8991Jayawardena, Jeyakumar, Francis, Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries, Diabetes & Metabolic Syndrome: Clinical Research & Reviews,
doi:10.1016/j.dsx.2021.03.006Lin, Mulick, Mathur, The association between vitamin D status and COVID-19 in England: A cohort study using UK Biobank, PLoS ONE,
doi:10.1371/journal.pone.0269064Maghbooli, Sahraian, Ebrahimi, vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PloS one
Ranathunga, Naveenkumar, Sumanatilleke, vitamin D deficiency, associated factors & possible adverse outcomes in a tertiary care institute in Sri Lanka, Sri Lanka Journal of Diabetes Endocrinology and Metabolism
References, None
Weir, Thenappan, Bhargava, Does vitamin D deficiency increase the severity of COVID-19? Clinical medicine
